UB317
TargetsGLP-1; GIP
IndicationsNonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; Obstructive sleep apnoea syndrome; Cardiac failure with preserved ejection fraction
ClinicalIND
TherapeuticsMetabolic & Endocrinology
ModalitiesPeptide
How can we help you?
Receive insights into the latest events and regulatory updates
Sent directly to your email
Get industry insights and Unibest news here
Contact Us →